PsychPlus

PsychPlus in Glendale, Wisconsin, serving the North Milwaukee area, offers Spravato (esketamine), an FDA-approved treatment for adults with treatment-resistant depression, administered in-office under clinical supervision. Spravato acts on a different brain pathway than conventional antidepressants, offering relief for patients who have not found success with other medications.

The practice focuses on personalized, evidence-based psychiatric care with a thorough upfront evaluation to identify the most effective treatment for each patient.

Beyond Spravato, the clinic provides psychiatry, therapy, medication management, and neuropsychological testing, with both in-person and virtual appointments available. Walk-ins are welcome Monday through Friday, and PsychPlus is in-network with most insurance, including Medicare and Medicaid.